Loading stock data…
Tempus AI, Inc. (TEM)
$42.69-3.32 (-7.22%)
Market ClosedLast close Jul 24
Tempus AI, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Tempus AI, Inc. in the Healthcare sector is trading at $42.69 with a market capitalization of $8.5B. Wall Street consensus targets $66.57 (14 analysts), implying a +55.9% move over the next 12 months. The stock is currently near its 52-week low of $41.73, remaining 29.7% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. Risk note: RSI 23 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +55.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 23) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $348.12M↓ | $367.21M↑ | $334.21M↑ | $314.63M↑ | $255.74M |
| Gross Profit | $222.04M↓ | $237.71M↑ | $209.94M↑ | $195.04M↑ | $155.20M |
| Operating Income | -$84.71M↓ | -$61.41M↓ | -$61.00M↑ | -$61.77M↑ | -$68.69M |
| Net Income | -$125.92M↓ | -$54.17M↑ | -$79.98M↓ | -$42.84M↑ | -$68.04M |
Peer Comparison
JNJUNHPFE
Fundamentals
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytic...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.53B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-72.74%
Volume
Today's trading volume
5.64M
Recent News
Cathie Wood Is Doubling Down on Tesla Again. Why She’s Buying When Everyone Else Is Selling.
ARK Invest bought about 160,000 shares of Tesla stock on Thursday, as shares of the EV maker plunged.
Tempus AI Stock Before Q2 Earnings Release: To Buy, Hold or Sell?
TEM heads into Q2 earnings with 21.3% expected revenue growth, strong diagnostics demand and AI deals, but near-term margin pressure remains.
Cathie Wood buys $8.7 million of beaten-down AI stock
Cathie Wood, CEO of Ark Investment Management, is known for buying her favorite growth stocks during sharp pullbacks. That's exactly what she's doing with Tempus AI (TEM) after the healthcare technology stock tumbled 14% over the past week. In 2025, the flagship Ark Innovation ETF gained ...
Tempus AI (TEM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Tempus (TEM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tempus makes $1.5B bet to corner cancer-test market
Tempus AI (TEM) spent three years selling someone else's cancer test. On Monday, July 20, it decided to just buy the whole thing. The AI diagnostics company agreed to acquire Personalis (PSNL) in a deal valued at $1.5 billion. The move hands Tempus full control of a test that spots cancer ...